BSE:590006

Stock Analysis Report

Executive Summary

Amrutanjan Health Care Limited produces and sells ayurvedic pain balms in India.

Snowflake

Fundamentals

Flawless balance sheet with proven track record and pays a dividend.

Share Price & News

How has Amrutanjan Health Care's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

1.6%

590006

2.1%

IN Pharmaceuticals

1.6%

IN Market


1 Year Return

34.5%

590006

-21.1%

IN Pharmaceuticals

0.8%

IN Market

Return vs Industry: 590006 exceeded the Indian Pharmaceuticals industry which returned -21.1% over the past year.

Return vs Market: 590006 exceeded the Indian Market which returned 0.8% over the past year.


Shareholder returns

590006IndustryMarket
7 Day1.6%2.1%1.6%
30 Day14.3%-6.9%1.5%
90 Day12.3%-7.2%-3.3%
1 Year35.5%34.5%-20.4%-21.1%2.7%0.8%
3 Year29.3%26.6%-26.3%-27.8%22.0%16.0%
5 Year144.4%135.2%-11.1%-13.8%42.3%29.3%

Price Volatility Vs. Market

How volatile is Amrutanjan Health Care's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Amrutanjan Health Care undervalued compared to its fair value and its price relative to the market?

38.84x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Undervalued: 590006 (₹340.45) is trading above our estimate of fair value (₹104.71)

Significantly Undervalued: 590006 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 590006 is poor value based on its PE Ratio (38.8x) compared to the Pharmaceuticals industry average (15.4x).

PE vs Market: 590006 is poor value based on its PE Ratio (38.8x) compared to the Indian market (13.1x).


Price to Earnings Growth Ratio

Low PEG Ratio: 590006 is poor value based on its PEG Ratio (3x)


Price to Book Ratio

PB vs Industry: 590006 is overvalued based on its PB Ratio (6.8x) compared to the IN Pharmaceuticals industry average (1.5x).


Next Steps

Future Growth

How is Amrutanjan Health Care forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

13.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 590006's forecast earnings growth (13.1% per year) is above the savings rate (7.6%).

Earnings vs Market: 590006's earnings (13.1% per year) are forecast to grow slower than the Indian market (18.3% per year).

High Growth Earnings: 590006's earnings are forecast to grow, but not significantly.

Revenue vs Market: 590006's revenue (12.3% per year) is forecast to grow faster than the Indian market (11.4% per year).

High Growth Revenue: 590006's revenue (12.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: Insufficient data to determine if 590006's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Amrutanjan Health Care performed over the past 5 years?

6.1%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: 590006's earnings have grown by 6.1% per year over the past 5 years.

Accelerating Growth: 590006's earnings growth over the past year (28.1%) exceeds its 5-year average (6.1% per year).

Earnings vs Industry: 590006 earnings growth over the past year (28.1%) exceeded the Pharmaceuticals industry 16.4%.


Return on Equity

High ROE: 590006's Return on Equity (17.6%) is considered low.


Return on Assets

ROA vs Industry: 590006 has a higher Return on Assets than the Pharmaceuticals industry average last year.


Return on Capital Employed

ROCE Improving: 590006's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is Amrutanjan Health Care's financial position?


Financial Position Analysis

Short Term Liabilities: 590006's short term assets (₹1.4B) exceeds its short term liabilities (₹361.2M)

Long Term Liabilities: 590006's short term assets (1.4B) exceeds its long term liabilities (57.6M)


Debt to Equity History and Analysis

Debt Level: 590006 is debt free.

Reducing Debt: 590006 has no debt compared to 5 years ago when its debt to equity ratio was 7.3%.

Debt Coverage: 590006 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 590006 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: 590006 has a high level of physical assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if 590006's debt is covered by short term assets.


Next Steps

Dividend

What is Amrutanjan Health Care's current dividend yield, its reliability and sustainability?

0.63%

Current Dividend Yield


Dividend Yield vs Market

company0.6%marketbottom25%0.6%markettop25%2.5%industryaverage0.9%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: 590006's dividend (0.63%) is higher than the bottom 25% of dividend payers in the Indian market (0.6%).

High Dividend: 590006's dividend (0.63%) is low compared to the top 25% of dividend payers in the Indian market (2.49%).

Stable Dividend: 590006's dividends per share have been stable in the past 10 years.

Growing Dividend: 590006's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (24.5%), 590006's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

What is the CEO of Amrutanjan Health Care's salary, the management and board of directors tenure and is there insider trading?

7.7yrs

Average board tenure


CEO

Sivalenka Prasad (45yo)

0yrs

Tenure

₹12,856,933

Compensation

Mr. Sivalenka Sambhu Prasad, B.Tech (USA), M.B.A. (USA) has been the Managing Director of Amrutanjan Health Care Limited and serves as its Chairman since February 13, 2012. He has been Director of Amrutanj ...


CEO Compensation Analysis

Compensation vs. Market: Insufficient data to establish whether Sivalenka's total compensation is reasonable compared to companies of similar size in the Indian market.

Compensation vs Earnings: Sivalenka's compensation has been consistent with company performance over the past year.


Board Age and Tenure

7.7yrs

Average Tenure

62yo

Average Age

Experienced Board: 590006's board of directors are considered experienced (7.7 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • P. Easwaradas

    President of OTC Division

    • Tenure: 0yrs
  • Sivalenka Prasad (45yo)

    Chairman & MD

    • Tenure: 0yrs
    • Compensation: ₹12.86m
  • S. Jeyakanth

    Chief Operating Officer

    • Tenure: 0yrs
  • M. Srinivasan

    Compliance Officer & Company Secretary

    • Tenure: 4.2yrs
    • Compensation: ₹1.00m
  • R. Narayanan

    Chief Sales Officer

    • Tenure: 0yrs
  • P. Kannan

    General Manager of Human Resources & Administration

    • Tenure: 0yrs
  • N. Swaminathan

    Chief Financial Officer

    • Tenure: 1.9yrs

Board Members

  • Sivalenka Prasad (45yo)

    Chairman & MD

    • Tenure: 0yrs
    • Compensation: ₹12.86m
  • Pasumarthi Murthi (85yo)

    Non-Executive Director

    • Tenure: 30.2yrs
    • Compensation: ₹420.00k
  • Hanehallibhandimat Shetty (87yo)

    Non-Executive & Independent Director

    • Tenure: 16.3yrs
    • Compensation: ₹680.00k
  • Vembu Swaminathan (54yo)

    Non-Executive Independent Director

    • Tenure: 4.4yrs
    • Compensation: ₹820.00k
  • Sambasivam Vydeeswaran (73yo)

    Non-Executive Independent Director

    • Tenure: 5.1yrs
    • Compensation: ₹490.00k
  • Marie Pereira (56yo)

    Non-Executive Independent Director

    • Tenure: 7.9yrs
    • Compensation: ₹440.00k
  • Govindan Raghavan (62yo)

    Non-Executive Independent Director

    • Tenure: 4.4yrs
    • Compensation: ₹790.00k

Company Information

Amrutanjan Health Care Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Amrutanjan Health Care Limited
  • Ticker: 590006
  • Exchange: BSE
  • Founded: 1893
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₹10.204b
  • Shares outstanding: 29.23m
  • Website: https://www.amrutanjan.com

Number of Employees


Location

  • Amrutanjan Health Care Limited
  • No.103, Luz Church Road
  • Mylapore
  • Chennai
  • Tamil Nadu
  • 600004
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
590006BSE (Mumbai Stock Exchange)YesEquity SharesININRMay 2005
AMRUTANJANNSEI (National Stock Exchange of India)YesEquity SharesININRMay 2005

Biography

Amrutanjan Health Care Limited produces and sells ayurvedic pain balms in India. It operates through OTC products, Beverages, and Others segments. The company offers pain management products, including pai ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/14 12:32
End of Day Share Price2019/10/14 00:00
Earnings2019/06/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.